---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040216"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2026-08-26T19:10:39+00:00"
generated_at: "2026-08-26T19:11:28.664292+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tevogen shareholders approve 100M share increase to 2024 incentive plan and written consent amendment

## Summary
- Stockholders approved Plan Amendment increasing shares available under 2024 Omnibus Incentive Plan by 100,000,000 to 102,800,000 initial limit.
- Approved charter amendment permitting stockholder action by written consent, effective Aug 26, 2026.
- Elected Dr. Keow Lin Goh and Victor Sordillo as Class II directors for three-year terms.
- Ratified KPMG LLP as independent auditor for fiscal year ending Dec 31, 2026.
- Votes: Plan Amendment 5,322,668 for; charter amendment 5,382,051 for; quorum 5,956,141 shares.

## SEC filing metadata
- accession: 0001493152-26-040216
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2026-08-26T19:10:39+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/0001493152-26-040216-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315226040216/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040216
- JSON: https://secwatch.observer/filing/0001493152-26-040216.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040216.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.